JPRN-UMIN000005057尚未招募未知
The effect of Pioglitazone in arteriosclerosis obliterans(ASO) patients with type 2 diabetes mellitus or impaired glucose tolerance - The effect of Pioglitazone in arteriosclerosis obliterans(ASO) patients with type 2 diabetes mellitus or impaired glucose tolerance
Sanda City Hospital0 个研究点目标入组 40 人开始时间: 2011年2月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with cardiac failure at present or in the past Patients with severe renal dysfunction Patients with severe liver dysfunction
研究者
相似试验
已完成
2 期
Effects of pioglitazone on coronary atherosclerotic plaques of patients with impaired glucose tolerance or type 2 diabetes mellitus:a randomized,open rabelled,prospective study.Impaired glucose tolerance or type 2 diabetes mellitus with coronary artery diseaseJPRN-C000000230Chiba University Graduate School of Medicine40
已完成
不适用
Improvement effects of pioglitazone on endothelial function after sirolimus-eluting stent (Cypher stent) implantation: a randomized, open rabelled, prospective study.coronary artery diseaseJPRN-UMIN000000899Chiba University Graduate School of Medicine50
已完成
4 期
Effect of Pioglitazone on TIMP-3 and TACE in Type 2 DiabetesType 2 DiabetesNCT01223196The University of Texas Health Science Center at San Antonio60
已完成
2 期
Pioglitazone Intervention for Coronary Atherosclerosis in Patients with Acute Coronary Syndrome.Acute coronary syndromeJPRN-C000000344Department of Cardiovascular Medicine Saitama Medical University International Medical Center100
已完成
2 期
Pioglitazone Intervention for Coronary Atherosclerosis in Patients with Metabolic Syndrome.Coronary atherosclerosis Metabolic syndromeJPRN-C000000332Department of Cardiovascular Medicine Saitama Medical University International Medical Center100